Literature DB >> 10996987

Neonatal meningitis: mortality, cerebrospinal fluid, and microbiological findings.

E Nel1.   

Abstract

This study describes the bacteriology, cerebrospinal fluid (CSF) findings, and mortality of neonatal meningitis over an 11-year period. The minimum incidence of neonatal meningitis at Tygerberg Hospital is 0.72/1000 live births/year. Eighty-eight patients were included in the study. Median birthweight and age at diagnosis were 2320 g and 12 days, respectively. CSF culture was positive in 77 (88 per cent), blood culture was positive in 51 (57 per cent), and Gram stain was positive in 58 (66 per cent). The most frequently cultured organisms were Group B Streptococcus, Klebsiella pneumoniae, and E. coli. Thirty (34 per cent) patients died, the majority within 72 h after admission. The death rate was significantly increased in babies with a birthweight of less than 1500 g (59 per cent). Increased total CSF protein was associated with an increased risk of death. Normal CSF cell count, total CSF protein and CSF glucose were found in six infants.

Entities:  

Mesh:

Year:  2000        PMID: 10996987     DOI: 10.1093/tropej/46.4.237

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  3 in total

Review 1.  Neonatal meningitis.

Authors:  P T Heath; N K Nik Yusoff; C J Baker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

2.  Etiology, clinical findings and laboratory parameters in neonates with acute bacterial meningitis.

Authors:  Hassan Boskabadi; Elahe Heidari; Maryam Zakerihamidi
Journal:  Iran J Microbiol       Date:  2020-04

3.  Bacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics.

Authors:  Olivia Swann; Dean B Everett; Jeremry S Furyk; Ewen M Harrison; Malango T Msukwa; Robert S Heyderman; Elizabeth M Molyneux
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.